Shanghai ZJ Bio-Tech Co., Ltd — Investor Relations & Filings
Shanghai ZJ Bio-Tech Co., Ltd., operating under the brand Liferiver, specializes in the development, manufacture, and distribution of molecular diagnostic reagents and equipment. The company’s core expertise lies in real-time PCR technology, providing a comprehensive portfolio of over 400 diagnostic kits. These solutions target a broad spectrum of infectious diseases, including viral hepatitis, respiratory infections, sexually transmitted diseases, and zoonotic pathogens. Beyond clinical diagnostics, the company offers specialized kits for food safety testing and veterinary health monitoring. Its products are utilized by clinical laboratories, hospitals, and public health institutions worldwide. Many diagnostic assays have achieved international recognition through CE marking and World Health Organization (WHO) listings. The company focuses on delivering high-sensitivity, high-specificity molecular tools to facilitate rapid pathogen detection and disease management.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 之江生物:关于召开2025年年度业绩说明会的公告 | 2026-05-07 | Chinese | |
| 之江生物:关于2025年第三次以集中竞价交易方式回购公司股份的进展公告 | 2026-05-07 | Chinese | |
| 之江生物:董事会审计委员会2025年度履职情况报告 | 2026-04-23 | Chinese | |
| 之江生物:审计委员会对会计师事务所2025年度履行监督职责情况的报告 | 2026-04-23 | Chinese | |
| 之江生物:董事会对独立董事独立性自查情况的专项报告 | 2026-04-23 | Chinese | |
| 之江生物:2025年度营业收入扣除情况的专项审核说明 | 2026-04-23 | Chinese |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 44272038 | 之江生物:关于召开2025年年度业绩说明会的公告 | 2026-05-07 | Chinese | ||
| 44267750 | 之江生物:关于2025年第三次以集中竞价交易方式回购公司股份的进展公告 | 2026-05-07 | Chinese | ||
| 39904944 | 之江生物:董事会审计委员会2025年度履职情况报告 | 2026-04-23 | Chinese | ||
| 39904936 | 之江生物:审计委员会对会计师事务所2025年度履行监督职责情况的报告 | 2026-04-23 | Chinese | ||
| 39904928 | 之江生物:董事会对独立董事独立性自查情况的专项报告 | 2026-04-23 | Chinese | ||
| 39904917 | 之江生物:2025年度营业收入扣除情况的专项审核说明 | 2026-04-23 | Chinese | ||
| 39904680 | 之江生物:2025年年度报告 | 2026-04-23 | Chinese | ||
| 39904678 | 之江生物:董事会提名委员会关于公司第六届董事会非独立董事候选人任职资格的审查意见 | 2026-04-23 | Chinese | ||
| 39904676 | 之江生物:公司章程 | 2026-04-23 | Chinese | ||
| 39904664 | 之江生物:董事、高级管理人员薪酬管理制度 | 2026-04-23 | Chinese | ||
| 39904650 | 之江生物:关于董事会换届选举的公告 | 2026-04-23 | Chinese | ||
| 39904643 | 之江生物:关于上海之江生物科技股份有限公司非经营性资金占用及其他关联资金往来情况汇总表的专项审计报告 | 2026-04-23 | Chinese | ||
| 39904577 | 之江生物:2025年度独立董事述职报告(徐强国) | 2026-04-23 | Chinese | ||
| 39904575 | 之江生物:关于2025年第三次以集中竞价交易方式回购公司股份的进展公告 | 2026-04-02 | Chinese | ||
| 39904568 | 之江生物:关于自愿披露公司产品获得相关认证的公告 | 2026-03-19 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Shanghai ZJ Bio-Tech Co., Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58332/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58332 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58332 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58332 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58332}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Shanghai ZJ Bio-Tech Co., Ltd (id: 58332)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.